HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pediatricians Double Recommended Vitamin D Intake, Suggest Earlier Use

This article was originally published in The Tan Sheet

Executive Summary

The American Academy of Pediatrics doubles its recommendation for daily vitamin D intake by infants, children and adolescents to 400 IU and advises earlier supplementation with the vitamin

You may also be interested in...



FDA Warns Oversized, Unmarked Droppers Could Lead To Vitamin D Overdose

FDA recommends firms limit the size of droppers accompanying liquid vitamin D supplements for infants to the maximum recommended daily amount to reduce the risk of overdose

“All-Time High” Vitamin D Awareness May Make New DRI Less Relevant – CRN

Consumer enthusiasm for vitamin D is outpacing the research community and may make upping the dietary reference intake level less relevant to the supplement industry

New Dietary Supplement Products In Brief

Drops of D3: Carlson Laboratories launches liquid Ddrops, tasteless and natural vitamin D3 in formulations for adults and infants available at health food stores nationwide. The Arlington Heights, Ill.-based firm says one drop is added to a meal to obtain the desired dose. The Baby Ddrops product is available at a suggested retail price of $16.98 for 400 IU, and Ddrops are available in 1,000 IU for $18.98 and 2,000 IU for $19.98...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS137511

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel